id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-N-0002-0039,FDA,FDA-2012-N-0002,Freedom of Information Summary NADA 141-068 BAYTRIL 100 Injectable Solution,Supporting & Related Material,Reference (internal unless indicated),2012-12-31T05:00:00Z,2012,12,,,2012-12-31T16:35:08Z,,0,0,09000064811a07bf
FDA-2012-N-0002-0036,FDA,FDA-2012-N-0002,Freedom of Information Summary ANADA 200-466 SPARMECTIN Plus Clorsulon,Supporting & Related Material,Freedom of Information Summary,2012-12-31T05:00:00Z,2012,12,,,2012-12-31T16:35:07Z,,0,0,090000648114c76f
FDA-2012-N-0002-0032,FDA,FDA-2012-N-0002,New Animal Drugs: Enrofloxacin; Melengestrol; Meloxicam; Pradofloxacin; Tylosin,Rule,Final Rule,2012-12-31T05:00:00Z,2012,12,2012-12-31T05:00:00Z,,2012-12-31T15:19:06Z,2012-31397,0,0,09000064811a03c6
FDA-2012-N-0002-0038,FDA,FDA-2012-N-0002,Freedom of Information Summary NADA 141-346 OroCAM,Supporting & Related Material,Freedom of Information Summary,2012-12-31T05:00:00Z,2012,12,,,2012-12-31T16:35:08Z,,0,0,09000064811a07bc
FDA-2012-N-0002-0034,FDA,FDA-2012-N-0002,Freedom of Information Summary NADA 141-340 SKYCIS 100,Supporting & Related Material,Freedom of Information Summary,2012-12-31T05:00:00Z,2012,12,,,2012-12-31T16:35:07Z,,0,0,090000648114c01f
FDA-2012-N-0002-0035,FDA,FDA-2012-N-0002,Freedom of Information Summary NADA 141-342 ALFAXAN,Supporting & Related Material,Freedom of Information Summary,2012-12-31T05:00:00Z,2012,12,,,2012-12-31T16:35:07Z,,0,0,090000648114c76d
FDA-2012-N-0002-0033,FDA,FDA-2012-N-0002,Freedom of Information Summary NADA 141-339 OVUGEL,Supporting & Related Material,Freedom of Information Summary,2012-12-31T05:00:00Z,2012,12,,,2012-12-31T16:35:07Z,,0,0,090000648114c01d
FDA-2012-N-0002-0037,FDA,FDA-2012-N-0002,Freedom of Information Summary NADA 141-344 VERAFLOX Suspension for Cats,Supporting & Related Material,Freedom of Information Summary,2012-12-31T05:00:00Z,2012,12,,,2012-12-31T16:35:08Z,,0,0,09000064811a07b7
FDA-2012-N-0002-0031,FDA,FDA-2012-N-0002,New Animal Drugs; Approvals; Changes of Sponsor; Change of Sponsor's Name; Change of Sponsor's Address: Alfaxalone; Ivermectin and Clorsulon; Narasin; Triptorelin,Rule,Final Rule,2012-10-23T04:00:00Z,2012,10,2012-10-23T04:00:00Z,,2012-10-23T13:10:53Z,2012-25989,0,0,090000648114c4e5
FDA-2012-N-0002-0029,FDA,FDA-2012-N-0002,Freedom of Information Summary NADA 141-277 Spinosad,Supporting & Related Material,Freedom of Information Summary,2012-10-09T04:00:00Z,2012,10,,,2012-10-09T16:25:17Z,,0,0,0900006481138f8f
FDA-2012-N-0002-0030,FDA,FDA-2012-N-0002,Freedom of Information Summary NADA 141-343 Tilmicosin Phosphate and Monensin,Supporting & Related Material,Freedom of Information Summary,2012-10-09T04:00:00Z,2012,10,,,2012-10-09T16:35:53Z,,0,0,0900006481138f91
FDA-2012-N-0002-0028,FDA,FDA-2012-N-0002,New Animal Drugs: Change of Sponsor's Address; Monensin; Spinosad; Tilmicosin,Rule,Final Rule,2012-10-04T04:00:00Z,2012,10,2012-10-04T04:00:00Z,,2012-10-04T13:06:07Z,2012-24475,0,0,0900006481133f57
FDA-2012-N-0002-0027,FDA,FDA-2012-N-0002,New Animal Drugs: Butorphanol; Doxapram; Triamcinolone; Tylosin,Rule,Final Rule,2012-10-03T04:00:00Z,2012,10,2012-10-03T04:00:00Z,2012-10-16T03:59:59Z,2012-10-03T14:49:23Z,2012-24331,0,0,09000064811328d5
FDA-2012-N-0002-0026,FDA,FDA-2012-N-0002,New Animal Drugs for Use in Animal Feeds: Monensin,Rule,Final Rule,2012-09-19T04:00:00Z,2012,9,2012-09-19T04:00:00Z,,2012-09-19T13:25:22Z,2012-23065,0,0,090000648111dfc3
FDA-2012-N-0002-0025,FDA,FDA-2012-N-0002,New Animal Drugs: Change of Sponsor; Change of Sponsor Address; Lincomycin and Spectinomycin Soluble Powder; Sulfadimethoxine Oral Solution and Soluble Powder; Tiamulin,Rule,Final Rule,2012-09-14T04:00:00Z,2012,9,2012-09-14T04:00:00Z,,2012-09-14T13:58:39Z,2012-22646,0,0,090000648111719b
FDA-2012-N-0002-0024,FDA,FDA-2012-N-0002,New Animal Drugs: Enrofloxacin; Tylvalosin,Rule,Final Rule,2012-09-10T04:00:00Z,2012,9,2012-09-10T04:00:00Z,,2012-09-10T21:46:26Z,2012-22194,0,0,090000648110ec30
FDA-2012-N-0002-0021,FDA,FDA-2012-N-0002,Freedom of Information Summary NADA 141-326 Cephalexin,Supporting & Related Material,Freedom of Information Summary,2012-08-09T04:00:00Z,2012,8,,,2012-08-09T14:38:19Z,,0,0,09000064810ca980
FDA-2012-N-0002-0020,FDA,FDA-2012-N-0002,New Animal Drugs: Cephalexin; Fentanyl; Milbemycin Oxime and Praziquantel,Rule,Final Rule,2012-08-09T04:00:00Z,2012,8,2012-08-09T04:00:00Z,,2012-08-09T14:24:03Z,2012-19498,0,0,09000064810ca31f
FDA-2012-N-0002-0023,FDA,FDA-2012-N-0002,Freedom of Information Summary NADA 141-338 Milbemy Oxime and Praziquantel,Supporting & Related Material,Freedom of Information Summary,2012-08-09T04:00:00Z,2012,8,,,2012-08-09T14:54:21Z,,0,0,09000064810ca9df
FDA-2012-N-0002-0022,FDA,FDA-2012-N-0002,Freedom of Information Summary NADA 141-337 Fentanyl,Supporting & Related Material,Freedom of Information Summary,2012-08-09T04:00:00Z,2012,8,,,2012-08-09T14:45:49Z,,0,0,09000064810ca9d9
FDA-2012-N-0002-0019,FDA,FDA-2012-N-0002,"New Animal Drugs; Change of Sponsor; Change of Sponsor Address: Azaperone; Miconazole, Polymyxin B, and Prednisolone Suspension",Rule,Final Rule,2012-08-06T04:00:00Z,2012,8,2012-08-05T04:00:00Z,,2012-08-06T20:47:47Z,2012-19147,0,0,09000064810c2dc4
FDA-2012-N-0002-0017,FDA,FDA-2012-N-0002,Freedom of Information Summary NADA 141-263 Maropitant,Supporting & Related Material,Freedom of Information Summary,2012-07-03T04:00:00Z,2012,7,,,2012-07-03T15:25:37Z,,0,0,0900006481077b27
FDA-2012-N-0002-0016,FDA,FDA-2012-N-0002,Implantation or Injectable Dosage Form New Animal Drugs: Maropitant; Tildipirosin,Rule,Final Rule,2012-07-03T04:00:00Z,2012,7,2012-07-03T04:00:00Z,,2012-07-03T13:20:47Z,2012-16203,0,0,0900006481077f54
FDA-2012-N-0002-0018,FDA,FDA-2012-N-0002,Freedom of Information Summary NADA 141-334 Tildipirosin,Supporting & Related Material,Freedom of Information Summary,2012-07-03T04:00:00Z,2012,7,,,2012-07-03T15:34:44Z,,0,0,0900006481077b2a
FDA-2012-N-0002-0014,FDA,FDA-2012-N-0002,Conditionally Approved New Animal Drugs for Minor Use and Minor Species Masitinib,Rule,Final Rule,2012-06-15T04:00:00Z,2012,6,,,2012-06-15T15:29:02Z,2012-14635,0,0,090000648104c52f
FDA-2012-N-0002-0015,FDA,FDA-2012-N-0002,Freedom of Information Summary CNADA 141 308 KINAVET CA1,Other,Freedom of Information Summary (No Federal Register Publication),2012-06-15T04:00:00Z,2012,6,2012-06-15T04:00:00Z,,2024-11-12T05:04:56Z,,1,0,090000648104cd38
FDA-2012-N-0002-0013,FDA,FDA-2012-N-0002,New Animal Drugs: Change of Sponsor's Name,Rule,Final Rule,2012-06-04T04:00:00Z,2012,6,2012-06-04T04:00:00Z,,2012-06-05T13:11:11Z,2012-13409,0,0,0900006481031749
FDA-2012-N-0002-0012,FDA,FDA-2012-N-0002,New Animal Drugs Altrenogest Dexamethasone Florfenicol,Rule,Final Rule,2012-05-31T04:00:00Z,2012,5,,,2012-05-31T17:06:27Z,2012-13095,0,0,0900006481022d77
FDA-2012-N-0002-0011,FDA,FDA-2012-N-0002,New Animal Drugs; Changes of Sponsors: Estradiol; Estradiol Benzoate and Testosterone Propionate; Progesterone and Estradiol Benzoate; etc.,Rule,Final Rule,2012-05-30T04:00:00Z,2012,5,2012-05-30T04:00:00Z,,2012-05-30T16:01:07Z,2012-13010,0,0,09000064810215a5
FDA-2012-N-0002-0010,FDA,FDA-2012-N-0002,New Animal Drugs: Ceftiofur Sodium; Lincomycin Powder; Naracin; Tylosin,Rule,Final Rule,2012-05-17T04:00:00Z,2012,5,,,2012-05-17T13:34:00Z,2012-11937,0,0,090000648101233c
FDA-2012-N-0002-0009,FDA,FDA-2012-N-0002,Oral Dosage Form New Animal Drugs: Change of Sponsor; Griseofulvin Powder; Levamisole Hydrochloride Powder; Oxytetracycline Powder,Rule,Final Rule,2012-05-14T04:00:00Z,2012,5,2012-05-14T04:00:00Z,,2012-05-14T14:03:52Z,2012-11382,0,0,090000648100d835
FDA-2012-N-0002-0008,FDA,FDA-2012-N-0002,New Animal Drugs: Fomepizole; Change of Sponsor;Change of Sponsor Address; Change of Sponsor Name and Address,Rule,Final Rule,2012-05-07T04:00:00Z,2012,5,2012-05-07T04:00:00Z,,2012-05-07T13:22:04Z,2012-10892,0,0,0900006481006620
FDA-2012-N-0002-0006,FDA,FDA-2012-N-0002,Freedom of Information Summary NADA 141-209 Tylosin,Supporting & Related Material,Freedom of Information Summary,2012-05-03T04:00:00Z,2012,5,,,2012-05-03T16:25:46Z,,0,0,0900006481003fea
FDA-2012-N-0002-0005,FDA,FDA-2012-N-0002,New Animal Drugs: Ceftiofur Crystalline Free Acid; Gamithromycin; Tylosin,Rule,Final Rule,2012-05-03T04:00:00Z,2012,5,,,2012-05-03T14:20:44Z,2012-10632,0,0,090000648100430c
FDA-2012-N-0002-0007,FDA,FDA-2012-N-0002,Freedom of Information Summary ANADA 200-484 Tylosin,Supporting & Related Material,Reference (internal unless indicated),2012-05-03T04:00:00Z,2012,5,,,2012-05-03T16:27:15Z,,0,0,0900006481003fdc
FDA-2012-N-0002-0004,FDA,FDA-2012-N-0002,New Animal Drugs for Use in Animal Feeds; Tiamulin,Rule,Final Rule,2012-04-23T04:00:00Z,2012,4,2012-04-23T04:00:00Z,,2012-04-23T13:14:03Z,2012-09708,0,0,0900006480ff6023
FDA-2012-N-0002-0003,FDA,FDA-2012-N-0002,New Animal Drugs for Use in Animal Feeds: Tiamulin,Rule,Final Rule,2012-04-17T04:00:00Z,2012,4,2012-04-17T04:00:00Z,,2012-04-17T16:22:04Z,2012-09196,0,0,0900006480ff2822
FDA-2012-N-0002-0002,FDA,FDA-2012-N-0002,Oral Dosage Form New Animal Drugs: Lincomycin Hydrochloride Soluble Powder; Penicillin G Potassium in Drinking Water; Tetracycline Powder; Change of Sponsor,Rule,Final Rule,2012-04-09T04:00:00Z,2012,4,2012-04-09T04:00:00Z,,2012-04-09T13:48:12Z,2012-08322,0,0,0900006480fec060
FDA-2012-N-0002-0001,FDA,FDA-2012-N-0002,New Animal Drugs for Minor Use and Minor Species; CFR Correction,Rule,,2012-03-28T04:00:00Z,2012,3,2012-03-28T04:00:00Z,,2012-03-28T17:35:51Z,2012-07532,0,0,0900006480fe2f3e